Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient has primary Type II hyperlipidemia or mixed dyslipidemia.~* If the patient is currently taking a lipid modifying medication other than Zocor \& he/she is willing to discontinue this medication~* LDL-C levels and/or non HDL-C levels above normal.~* Reasonable compliance with a standard cholesterol-lowering diet for a minimum of 4 weeks prior to screening and for the duration of the study.~Exclusion Criteria:~* Patient has an allergy, hypersensitivity, or intolerance to niacin, statins, or their derivatives.~* HbA1c ≥ 9% in diabetic patients

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).